Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus

被引：78

作者：

Cuenca-Estrella, M ^{[1
]}

Rodríguez-Tudela, JL ^{[1
]}

Mellado, E ^{[1
]}

Martínez-Suárez, JV ^{[1
]}

Monzón, A ^{[1
]}

机构：

[1] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Micol, Madrid 28220, Spain

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1998年 / 42卷 / 04期

关键词：

D O I：

10.1093/jac/42.4.531

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Voriconazole was compared with amphotericin B and itraconazole by a modification of the NCCLS microdilution reference method for yeasts against 62 clinical isolates of Aspergillus fumigatus. MICs of voriconazole were slightly lower than those of amphotericin B and itraconazole. The MIC of voriconazole at which 90% of isolates were inhibited was 1 mg/L and the MIC range was 0.25-2 mg/L. Voriconazole is a new antifungal agent with potential for use in the treatment of A. fumigatus infections.

引用

页码：531 / 533

页数：3

共 10 条

[1] BENNETT JE, 1995, PRINCIPLES PRACTICE, P2306
[2] Itraconazole resistance in Aspergillus fumigatus
Denning, DW
Venkateswarlu, K
Oakley, KL
Anderson, MJ
Manning, NJ
Stevens, DA
Warnock, DW
Kelly, SL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) : 1364 - 1368
[3] Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
EspinelIngroff, A
Bartlett, M
Bowden, R
Chin, NX
Cooper, C
Fothergill, A
McGinnis, MR
Menezes, P
Messer, SA
Nelson, PW
Odds, FC
Pasarell, L
Peter, J
Pfaller, MA
Rex, JH
Rinaldi, MG
Shankland, GS
Walsh, TJ
Weitzman, I
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) : 139 - 143
[4] Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis
George, D
Miniter, P
Andriole, VT
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) : 86 - 91
[5] Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs
Martin, MV
Yates, J
Hitchcock, CA
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) : 13 - 16
[6] In vitro evaluation of voriconazole against some clinically important fungi
McGinnis, MR
Pasarell, L
Sutton, DA
Fothergill, AW
Cooper, CR
Rinaldi, MG
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) : 1832 - 1834
[7] Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis
Murphy, M
Bernard, EM
Ishimaru, T
Armstrong, D
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) : 696 - 698
[8] *NAT COMM CLIN LAB, 1997, N27A NCCLS
[9] IMPROVED MEDIUM FOR FLUCONAZOLE SUSCEPTIBILITY TESTING OF CANDIDA-ALBICANS
RODRIGUEZTUDELA, JL
MARTINEZSUAREZ, JV
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (01) : 45 - 48
[10] Schwartz S, 1997, BRIT J HAEMATOL, V97, P663, DOI 10.1046/j.1365-2141.1997.972911.x

← 1 →